Company Overview
- Headquarters
- 200 Clarendon Street, Boston MA
- Website
- aiolosbio.com
- Employees
- 14
- Industry
- BioTech/Drugs
Who is Aiolos Bio
Aiolos Bio is a clinical stage biopharmaceutical company headquartered in Boston, Massachusetts. The company employs 14 individuals and is dedicated to advancing treatments for respiratory diseases and immunological disorders. Aiolos Bio focuses on developing innovative therapies, with their current primary project being a groundbreaking anti-TSLP therapy designed to offer superior treatment benefits. Their target audience includes patients and caregivers seeking more effective and less burdensome treatment options for a range of immune conditions. The Aiolos team brings extensive experience in drug development, having successfully launched products for conditions such as asthma, rheumatoid arthritis, and IPF. They aim to attract like-minded individuals who share their passion for improving the lives of patients with respiratory illnesses and other immune disorders. For more information, visit aiolosbio.com.
Company Leadership
Companies Similar to Aiolos Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to Aiolos Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 803 | Deerfield, IL | 2010 | ||
| Buffalo, NY | ||||